Bayer's Nexavar hits endpont in thyroid cancer trial; AbbVie plans hiring in Ireland;

@FiercePharma: Dr Reddy's launches Propecia generic with 180-day exclusivity; worth $20M to Indian company, analysts say. Story | Follow @FiercePharma

> Bayer said its cancer treatment Nexavar hit a goal of improving the survival of patients with a certain type of thyroid cancer in a late-stage clinical trial. Report

> AbbVie ($ABBV), the newly independent pharma business of Abbott Laboratories ($ABT), will add 175 jobs in Ireland by 2015, the company said. Report

> Forest Laboratories ($FRX) settled its Bystolic patent litigation with Glenmark Pharma, allowing the Indian company to sell its generics three months before the patent expires. Report

> Denmark's pharma market is expected to grow by an average of 6.9% a year to reach $7.3 billion by 2020, up from $4 billion in 2011, says a new report, from GlobalData. Report

> Ulcerative colitis patients will drive drug sales to $3.7 billion over the next decade, double their current level, with AbbVie's Humira and Johnson & Johnson's ($JNJ) Simponi benefiting most, a report says. Report

Medical Device News

 @FierceMedDev: Cardiologist: Boston Scientific's S-ICD requires further trials. More | Follow @FierceMedDev

@MarkHFierce: A German company is rolling out a new diagnostic test for the early prediction of breast cancer. Release | Follow @MarkHFierce

 @DamianFierce: Smith & Nephew's quasi-spinout, Bioventus, is expanding its European reach. Story | Follow @DamianFierce

> Crescendo Bioscience draws $28M Series D for RA Dx. News

> FDA: Praxair's recalled oxygen tanks pose deadly fire risk. Item

Biotech News

 @FierceBiotech: Sanofi Pasteur, Sutro team up on #vaccine candidates. Item | Follow @FierceBiotech

@JohnCFierce: In biotech trifecta, startup lassos $31M, a CEO and a lead drug from Pfizer. More  | Follow @JohnCFierce

@RyanMFierce: Repligen took in $5M of potential $70M from Pfizer in deal for candidate against spinal muscular dystrophy. More | Follow @RyanMFierce

> Wellcome Trust gambles on biotech startups with new £200M fund. Story

> Biogen CEO Scangos hit with first big setback as ALS drug fails PhIII. News

Vaccines News

 @AlisonBFierce: Sanofi Pasteur MSD's recall of its typhoid vaccine has led to a shortage in the U.K. More | Follow @AlisonBFierce

> Sanofi Pasteur, Sutro team up on vaccine candidates. Item

> HIV therapeutic vaccine shows promise. More

> Emergent, VaxInnate sign pandemic flu vaccine deal. Article

Pharma Manufacturing News

> Questcor buys CMO that makes API for Acthar. More

> BASF gets Vascepa contract ahead of Pronova buyout. News

> Pakistan investigates cough syrup tied to 35 deaths. Item

> Russia pushes plan to buy domestically produced drugs. Story

> FDA warns docs to buy from approved suppliers. Article

And Finally... Should diet and depression be studied the same way diet has been tested in heart disease? Report